NEW YORK (GenomeWeb) – Roughly two years after it agreed to pay $518 million for Devgen and its portfolio of agricultural RNAi technologies, Syngenta announced this month that it is collaborating with Australian startup Nexgen to develop virus-resistant crop plants through microRNA targeting.
Just days after the acquisition of agricultural microRNA firm Rosetta Green by Monsanto was cleared by Israeli antitrust authorities, Rosetta Green’s former parent from Rosetta Genomics has opposed the deal.
Rosetta Green said this week that it has signed an agreement under which it licensed an undisclosed microRNA from Iowa State University for use in developing plants resistant to nematodes. Specific terms of the deal were not disclosed.
Rosetta Green announced last week that it has struck a research collaboration with German plant breeding firm KWS to discover microRNAs that can improve sugar beet.
Rosetta Green last week announced that it has successfully completed an experiment producing biologically active human growth hormone from algae.
Feb 23, 2012
Jan 12, 2012
Dec 22, 2011
Dec 19, 2011
Rosetta Genomics Sells Stake in Rosetta Green
Aug 4, 2011
Jul 21, 2011
Jul 14, 2011
May 19, 2011
Mar 10, 2011
Feb 24, 2011
Jul 29, 2010